Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Ahmed Zayed Obeidat, MD, PhD
Genetics and Schizophrenia: Key Ethical Considerations
Aaron Besterman, MD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Marisa McGinley, DO
Navigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
Charles Turck, PharmD, BCPS, BCCCP
Bimaje Akpa, MD
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Natalie Bareis, PhD, LMSW
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Glenn Wylie, DPhil
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Hank Mayer, MD
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Steven Paul, MD
Spotting the Signs: Early Identification and Management of Schizophrenia
Desiree Matthews, PMHNP-BC
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
From Pathology to Practice: The Role of Inflammation in MS Pathology
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Balancing Act: Immune Reconstitution vs Immune Suppression
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
PROs in MS: A New Era of Patient-Centric Care
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.